Project Grant R03DA063982
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Washington a $699,748 Project Grant on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal neurodevelopmental research on prenatal cannabis exposure. The research deliverables include prospective measurement of maternal cannabis use during pregnancy validated through weekly reports and urine-based assays, neonatal neurobehavioral examinations, and...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded the University of Southern California a $196,236 Project Grant on July 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate clinician preconceptions about cannabis use during pregnancy and their impact on prenatal care quality. The award funds a five-year research initiative (through June 30, 2030) led by Dr. Rachel Carmen Ceasar that employs natural language processing and artificial...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant of $171,822 on July 15, 2025, to the University of Maryland, Baltimore to conduct the "Effects of Prenatal and Postnatal Cannabis Use on Lactation and Maternal Bonding (LAMB)" study, funded under CFDA 93.279 (Drug Use and Addiction Research Programs). The research will investigate the effects of cannabis use during pregnancy and the postpartum period on maternal attachment,...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston Children's Hospital a $489,500 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning June 1, 2025 and concluding May 31, 2027. This research initiative develops and validates remote oral fluid testing procedures to assess cannabis non-use as a key outcome measure in clinical trials targeting younger adults aged 18-30 years with cannabis use disorder (CUD). The project...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Boston College $941,917 under the Drug Use and Addiction Research Programs (CFDA 93.279) on September 1, 2025, for a two-year project period concluding August 31, 2027. The award funds a cluster-randomized controlled trial implementing the Worker Input and Strategy Program (WISP), an evidence-based participatory organizational intervention designed to address workforce challenges in residential addiction treatment...
- Federal Grant Award Summary Michigan State University, in partnership with Henry Ford Health, received a $183,681 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded on March 15, 2026. The project, titled "Patient-Engaged Development and Testing of a Technology-Based Intervention to Reduce Prenatal Cannabis Use," will deliver a comprehensive intervention system designed to address increasing cannabis use among...
- Federal Project Grant Award Summary Dartmouth College received a $450,313 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) effective June 1, 2025, through May 31, 2027. The award funds research investigating the impact of psychotherapeutic advertising claims (PAC) and mental health warning labels on cannabis purchasing behaviors among light-to-moderate cannabis users experiencing depression and/or anxiety symptoms....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded the University of Vermont & State Agricultural College a $387,291 Project Grant, effective March 1, 2026, through December 31, 2030, under the Drug Use and Addiction Research Programs (CFDA 93.279). This research initiative delivers comprehensive neuroimaging and behavioral analysis services to delineate developmental windows of vulnerability to cannabis exposure and establish causal relationships between...
- Federal Project Grant Award Summary Boston College received a $323,809 project grant from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), awarded September 15, 2025, with completion by May 31, 2028. This research project examines state-level differences in how reproductive health policy changes—particularly abortion restrictions implemented since June 2022—affect maternal health...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Massachusetts General Hospital $532,166 under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 1, 2026, to develop and evaluate an innovative Family Care Planning (FCP) intervention addressing the growing public health crisis of prenatal substance exposure and opioid use disorder among pregnant and parenting women. The project, titled "Reimagining 'Plans of Safe Care:' Promoting Recovery, Family...
Boston College received a $155,000 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded May 1, 2026, with a completion date of April 30, 2028. This research project will examine the effects of state recreational cannabis legalization laws on disparities in prenatal substance use, including cannabis, tobacco, and alcohol consumption among pregnant women. The research leverages the Pregnancy Risk Assessment Monitoring System (PRAMS) data from 2016–2023, covering 25 states and the District of Columbia, to conduct a natural experiment analysis that isolates the causal effects of state cannabis legalization policies on maternal substance use outcomes and healthcare provider assessments. The project delivers two primary research products: (1) empirical analysis of the effects of state recreational cannabis laws on women's substance use during the preconception, prenatal, and postpartum periods, along with downstream effects on birth outcomes; and (2) evaluation of how state legalization policies affect healthcare providers' assessment and documentation of prenatal substance use. The research explicitly addresses gaps in understanding differential policy effects across demographic strata (race/ethnicity, education, age) and higher-risk populations with mental health symptoms, thereby generating evidence to inform public health policy responses to cannabis legalization and its disparate impacts on maternal and neonatal health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $155.0k | 5/12/26 |